Elekta wins Queens Award for export performance

25 April 2012

Elekta, a Stockholm-headquartered company developing oncology and neuroscience products, has received the Queen's Award for Enterprise 2012 in the International Trade category for the performance of its Crawley, UK plant.

The Queen’s Award for Elekta acknowledges continuous improvement in the company’s overseas sales, in addition to its steady growth of exports, calculated at 131% over the last six years.
 
“Elekta strives to create new cancer innovations that place the value of the patient first and creates a relationship-focused approach that incorporates trust and responsibility,” states Johan Sedihn, Executive Vice President, Elekta Oncology. “Elekta’s employees and clinical partners can be deservedly proud of The Queen’s Award and the innovative tradition of improving the lives of individuals with cancer. Our oncology innovations are shared with the world, while benefiting the UK manufacturing and industrial base.”
Employment opportunities in UK plant
Elekta’s job growth at the Crawley plant — from circa 400 to 680 employees in the last three years — in combination with its current plans to recruit approximately 80 employees throughout the next 12 months, supports its selection as the recipient of the Queen’s Award. Elekta also has worked to develop young talent by hiring 15 apprentices over the last seven years, many of whom are now in technical roles within the company and two who are undergoing training with the local College.
 
“Elekta has played a crucial role in the regional economy by employing 680 employees at the Crawley location with 1,000 manufacturing jobs in the supply chain across the UK,” says Johan Sedihn. “Accordingly, we are scaling up our recruitment in Crawley to maintain the pace of innovation for which Elekta is renowned.”

On April 13, Henry Smith MP visited Elekta’s Crawley facility. Mr Smith commented on the significance of Elekta’s new technology and what it means for the local economy: “This is a fascinating development for Elekta and for the visibility of Crawley as the site of medical innovation. Elekta also has a keen commitment to apprenticeships and science outreach, such as supporting STEMfest, and is exactly what we need to support science careers in school.”

 

To top